Background: The PainFree Smart Shock Technology (SST) study showed a low implantable cardioverter-defibrillator (ICD) inappropriate shock rate. However, the majority of patients were from Western countries with patient characteristics different from those in Japan. ICD shock rates using the novel SST algorithms in Japanese patients are still unknown.
INTRODUCTION
A number of large-scale clinical studies have shown that implantable cardioverter-defibrillators (ICDs) are one of the most effective therapies to prevent sudden cardiac death regardless of the underlying cardiac condition (ischemic or nonischemic) or the intended use (primary or secondary prevention). [1] [2] [3] [4] Although appropriate ICD shocks improve survival, shocks may cause anxiety and psychological distress and increase mortality. [5] [6] [7] [8] The PainFree SST clinical study was conducted to evaluate the efficacy of a novel suite of detection algorithms designated as "Smart Shock Technology." Use of this technology combined with modern programming led to a very low inappropriate shock rate in the range of 1.5% per year for dual-chamber ICDs. 9 Nevertheless, this clinical study was conducted mainly in Western countries and did not thoroughly reflect the patient background of the population from eastern Asia including Japan. It is known that patient baseline characteristics are different between Western countries and Japan. 10, 11 However, it is unknown if these differences lead to different outcomes including the occurrence of inappropriate shocks. In this study, ICD shock rates from Japanese and non-Japanese patients who were enrolled in the PainFree SST study were compared to elucidate the effectiveness of the discrimination algorithms in the Japanese population. The impact of differences in patient baseline characteristics on inappropriate shock rates was assessed in order to inform ICD patient management.
METHODS

Study design
The methods and primary results of the PainFree SST study have been published. 9 In brief, the study was a prospective, multicenter, global clinical study conducted mainly in the United States, Europe, Middle East, Asia, and Japan. The study enrolled patients who had a clinical indication for an ICD for either primary or secondary prevention of sudden cardiac death and intended to receive a single-chamber (SC) or dual-/triple-chamber (DC) Protecta R device (Medtronic plc, Minneapolis, MN, USA). The primary endpoint was the percentage of patients receiving at least one inappropriate shock at 12 months. Secondary endpoints included the percentage of patients receiving any inappropriate device therapy (i.e., shocks and/or antitachycardia pacing [ATP]) at 12 months, the causes of inappropriate shocks, the incidence of appropriate device therapy, and evaluation of any undertreatment of ventricular arrhythmias. All patients were followed until study closure but not less than 1 year. Total study duration was 4 years, from
September 2009 until September 2013.
Device programming was mostly "out of box" settings. Ventricular fibrillation (VF) detection zone was programmed with a detection interval of 320 ms. Ventricular tachycardia (VT) detection zone was recommended to be programmed OFF in primary prevention patients and left to physician discretion in secondary prevention patients. Discrimination algorithms were programmed ON, per the nominal "out of box" settings of the device. Supraventricular tachycardia (SVT) discrimination algorithms were active for median ventricular intervals ≥ 260 ms. In primary prevention patients, the VF number of intervals to detect (NID) was programmed to 30/40, which is clinically proven to safely reduce shocks. 12 Secondary prevention patients were randomized 1:1 to either VF NID 30/40 or 18/24. 13 Further details are described in the design paper. 14 The PainFree SST study was approved by the local institutional review boards and informed consent was obtained from each patient prior to any study procedures taking place. Episodes were adjudicated by an episode review committee comprising nine independent physicians who were not study investigators.
In this substudy, we compared subsets of PainFree SST study patients from Japan (JPN) and from other geographies (OJPN) to evaluate appropriate and inappropriate ICD shock rates in each group. Table 1 and averaged among the imputed data sets. Greedy matching was then implemented to find three OJPN patients to match one JPN patient. Standardized differences were used to assess balance between JPN and matched OJPN patients, and a value ≤ 0.25 was considered acceptable balance. Table S1 in the Online Appendix) and were largely of white/Caucasian race (80.9%). The follow-up durations of JPN and OJPN patients were 21 ± 6 months and 22 ± 10 months, respectively. There were many differences in baseline characteristics between the groups (Table 1) . Notably, Japanese patients had a higher average left ventricular ejection fraction (LVEF,
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TA B L E 1 Baseline characteristics
Patient characteristics Japan (N = 181)
Other geographies (N = 2,589) ACE = angiotensin-converting enzyme; ARB = angiotensin II receptor blocker; AV = atrioventricular; CRT-D = cardiac resynchronization therapy defibrillator; DC = dual chamber; ICD= implantable cardioverter defibrillator; LVEF = left ventricular ejection fraction; NYHA = New York Heart Association; SC = single chamber.
44% vs 31%, P < 0.0001), more received the ICD for secondary prevention (56% vs 29%, P < 0.0001), fewer had ischemic cardiomyopathy (17% vs 45%, P < 0.0001), more had permanent atrial fibrillation (AF, 19% vs 9%, P < 0.0001), and more used antiarrhythmic drugs (40% vs 17%, P < 0.0001). Permanent AF was present in 35.1% of Japanese patients implanted with SC ICDs (Table S2 in the Online Appendix).
Propensity score matching successfully identified a subgroup of OJPN patients comparable to the JPN patients (Table 1) , as demonstrated by standardized differences that were all less than 0.25, except for LVEF and Inotropic agent use ( Figure S1 in the Online Appendix).
Device programming
Although the majority of patients in this study were set to VF NID 30/40, a higher percentage of JPN patients were set to 18/24 than OJPN (28% vs 18%, P = 0.002) due to randomization of the VF NID in secondary prevention patients. In addition, fewer JPN patients were programmed with Sinus Tachycardia Discrimination ON (86% vs 98%, 
Appropriate shock
There was no difference in the incidence of appropriate shocks in JPN compared to OJPN, both overall and when stratified by indication ( Figure 1 , Online Appendix Figure S2 ). The appropriate shock rates at 12 months were 6.4% and 6.3% for JPN and OJPN, respectively (P = 0.95) (Figure 1 ). In addition, there was no difference in the incidence of appropriate shocks across other geographies (Online Appendix Figure S3 ).
Inappropriate shock
There was a higher incidence of inappropriate shocks in JPN compared to OJPN (at 12 months, 2.9% and 1.7%, respectively, P = 0.017, hazard ratio = 2.22) (Figure 2A ). The incidence rate of inappropriate therapy (shock and ATP) after 1 year postimplant was 4.7% in JPN.
Across OJPN geographies, the inappropriate shock rate was comparable except for a higher rate in Saudi Arabia (Online Appendix Figure S4 ).
In JPN patients, there was a difference in the inappropriate shock rate between patients with SC and DC devices (P = 0.01) ( Figure 2B ); however, there was no difference in the inappropriate shock rate when comparing JPN and OJPN patients with DC devices (P = 0.21).
Additionally, more JPN patients with inappropriate shocks had a history of permanent AF, compared to JPN patients without inappropriate shocks (P = 0.025) and OJPN patients with inappropriate shocks (P = 0.006, Online Appendix Table S3 ). The most frequent adjudicated cause of an inappropriate shock for both JPN and OJPN patients was AF or atrial flutter ( Table 2 ). The inappropriate shock rate was significantly higher for Japanese patients with permanent AF compared to OJPN patients with permanent AF (P = 0.004) but similar in patients without permanent AF (P = 0.52) ( Figure 2C ). After propensity matching to adjust for differences in baseline characteristics, there was no statistical difference in the inappropriate shock rate between JPN and OJPN (P = 0.51, Figure 3 ).
DISCUSSION
In a subanalysis of JPN patients and OJPN patients from the PainFree SST study, we found the appropriate shock rate was comparable between groups. The inappropriate shock rate was higher in JPN than that of OJPN; however, after adjusting for differences in baseline characteristics, there was no longer a difference in the rate of inappropriate shocks. To our knowledge, this is the first report comparing the rates of appropriate and inappropriate shocks between JPN and OJPN using patients from a single study.
Appropriate shock rate
Although it was anticipated that the appropriate shock rate would be higher in the Japanese population since there were more patients receiving the device for secondary prevention, 15 results from this report showed that the incidence of appropriate shock was similar between JPN and OJPN ( Figure 1 ). This may be related to the fact that the Japanese population in this study comprises patients with relatively good cardiac function, lower incidence of myocardial infarction, and fewer patients with ischemic cardiomyopathy, all of which have been reported to predict incidence of appropriate therapy (Online Appendix Figure S2 ). 16 Further research is warranted.
Inappropriate shock rate
Results from this subanalysis of the PainFree SST study demonstrated that the inappropriate shock rate was significantly higher in Japanese patients. This could be explained by the difference in patient baseline characteristics as demonstrated by the propensity adjusted analysis.
As seen in Table 1 AF, advanced SVT discrimination algorithms such as PR logic R cannot be utilized; thus, the diagnosis must rely on the rate, stability criteria, and morphology, which may have less specificity and result in more inappropriate shocks. 9 In the present study, JPN patients only demonstrated a higher inappropriate shock rate in patients implanted with SC ICDs and not in those with DC ICDs. Additionally, since it has been reported that a ventricular rate above 90-110 beats/min during AF increases the risk of inappropriate shock, 17,18 rate control during AF may also play a crucial role. In the ECOST trial, 19 the number of inappropriate shocks decreased by utilizing remote monitoring and diagnostic features of the ICD, facilitating early intervention to treat the conditions which may lead to inappropriate shocks. As such, rate control by utilizing remote monitoring could be an effective method to prevent inappropriate shocks.
Since secondary prevention use is the most common indication in Japan, the VT zone was programmed ON in many patients, with significantly longer detection interval than for OJPN, which may have increased the possibility of inappropriate shock. However, previous results from the PainFree SST study have shown that setting the VT zone ON did not affect the incidence rate of inappropriate shock.
Additionally, the rate was similar among primary and secondary prevention patients. 9
F I G U R E 1 Appropriate shocks in Japan (JPN) and other geographies (OJPN). Follow-up duration is shorter in Japan as the study started earlier in Europe than Japan Note: One inappropriate shock originally reported as due to other SVT was adjudicated again and the cause was changed to EGM noise after the publication of the primary results. 9 CRT-D = cardiac resynchronization therapy defibrillator; EGM = electrogram; ICD = implantable cardioverter defibrillator; SVT = supraventricular tachycardia. 
F I G U R E 3
Inappropriate shocks in Japanese patients (JPN) and propensity-matched patients from other geographies (Matched)
As differences in patient backgrounds between patients in JPN and OJPN may have contributed to the difference in inappropriate shock rate, a propensity analysis was performed. After propensity matching, the incidence rate of inappropriate shock was comparably low in JPN and OJPN. Ueda et al. have reported that the inappropriate shock rates in patients with a SC ICD or DC ICD were 19% or 12%, respectively, during 4.5 years of follow-up; however, the study excluded patients with a history of permanent AF. 20 Results from the largest-scale prospective registry study in Japan (Nippon Storm) have reported that the incidence rate of inappropriate therapy (shock and ATP) after 1 year postimplant was 6.7%, 21 which was higher than the 4.7% reported in this study. The registry period of Nippon Storm was almost the same as PainFree SST, and the patient backgrounds were similar; however, the implanted devices were different. Therefore, the difference in the incidence rate of inappropriate shock between these studies could support the effectiveness of Smart Shock Technology.
The results of this study may help guide Japanese physicians in both the choice and programming of ICD devices. Furthermore, knowledge of regional differences in patient characteristics and current practice regarding device therapy makes it possible to develop ICD device algorithms and programming strategies that are tailored to the region.
Limitations
Some limitations should be considered in interpreting the results of this study. The results were analyzed retrospectively and the number of Japanese patients was small. Study enrollment began later in Japan, thus the follow-up duration in Japanese patients is shorter; however, comparative results cover only the first 24 months postimplant, which is within the Japanese patient follow-up duration. Propensity score matching analysis was conducted using only the baseline data collected in the PainFree SST study and does not take into account data not collected in the study that may impact the results. The matching reduced, but did not fully balance, the difference between Japanese and OJPN patients on LVEF and the use of inotropic agents.
CONCLUSION
This is the first reported comparison of ICD shock rates between Japan and other geographies within the same study cohort. There was no difference in the appropriate shock rate between these two populations.
The inappropriate shock rate in Japan was low, although it was slightly higher compared to other geographies, and this was associated with differences in baseline characteristics including a higher prevalence of permanent AF and more use of single-chamber ICDs in patients with permanent AF in Japan. The inappropriate shock rates were comparable between the geographies after adjusting for differences in baseline characteristics.
